TENAX THERAPEUTICS, INC. — Director's Dealing 2017

Mar 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TENAX THERAPEUTICS, INC. (TENX)
CIK: 0000034956
Period of Report: 2017-03-15

Reporting Person: Kelley John P (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-15	Common Stock	A	213420	—	Acquired	1379931	Direct
2017-03-15	Common Stock	F	96999	$0.68	Disposed	1282932	Direct

Footnotes

F1: Represents shares of common stock issued as payment of a portion of Mr. Kelley's bonus set forth in his employment agreement.

F2: Represents shares withheld in satisfaction of tax withholding obligations.